4Tian S, Kusano e, Ohara T, et al. Cystatin C measurement and its practical use in patients with various renal diseases [J].Clin Nephrol, 2002, 48:104-108
6Fian M, husano E, Ohara T, et al . Cystatin C measurement and its practival use in patients with various renal diseases [J].Clin Nephrol, 2003, 22:102-109
7Vlaskou D, Hofmann W, Guder WG, et al.Human neutral brush border endopeptidase EC 3. 4. 24. 11 in urine, its isolation, characterization and activity in renal disease[J].Clin Chim Acta, 2000,297:103-121
8Haskou E, Hofmann W, Guder WG, et al. Human neutral brush border endopeptidase EC 3.4.24.11 in urine, its isolation, characterization and activity in renal disease[J]. Clin Chim Acta, 2002,196:120.125
3[1]Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (Cystatin C) amongst the cysteine proteinase inhibitors[J ]. Biochem Biophys Res Commun, 1984, 120:631.
4[2]Sirmonsen O, Grubb A, Thysell H. The Blood serum concentration of cystatin C as a measure of glomerular filtration rate[J ]. Scand J Clin Lab Invest, 1985, 45:97.
5[3]Tian S, Kusano E, Tabei K, et al. Cystatin C measurement and its practical use in patients with various renal diseases[J ]. Clin Nephrol,1997, 48:104.
6[4]David JN, Hansa T, Robert GD, et al. Serum Cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine[J]. Kidney International, 1995, 47:312.
7[5]Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle enhanced immunonephelometry on the Behring nephelometer systems BNA,BNII[J ]. Clin Chem, 1997, 43:1016.
8[6]Fanos V, Mussap M, Plebani M, et al. Cystatin C in paediatric nephrology. Present situation and prospects [J ]. Minerva-Pediatr,1999, 51:167.
9[7]Jung K, Jung M. Cystatin C: a promising marker of glomerular filtration rate to replace creatinine[J]. Nephron, 1995, 70:370.
10[8]Ylinen EA, Ala Houhala M, Harmoinen AP, et al. Cystatin C as a marker for glomemlar filtration rate in pediatric patients[J ]. Pediatr Nephrol, 1999, 13:506.
